Literature DB >> 18285538

Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience.

V A Shah1, R H Kardon, A G Lee, J J Corbett, M Wall.   

Abstract

OBJECTIVE: To evaluate recurrent or delayed worsening of papilledema and visual function in patients with idiopathic intracranial hypertension (IIH) followed for more than 10 years.
METHODS: This is an Institutional Review Board approved retrospective chart review of 410 patients with the diagnosis of IIH evaluated at the University of Iowa Hospitals and Clinics from January 1984 to January 1996. Of the 410 patients, 20 patients with IIH who were followed over 10 years at the neuro-ophthalmology clinic met the inclusion criteria. Three neuro-ophthalmologists independently evaluated and graded the visual field examinations and optic disc stereo-photographs for each follow-up visit (median = 15).
RESULTS: Of the 20 patients, 11 demonstrated a stable course of disease without worsening in papilledema or visual field, and 9 patients worsened after a stable course. Of these 9 patients, 6 patients experienced delayed worsening (range: 28 to 135 months from presentation) and 3 patients had recurrence after resolution of papilledema 12 to 78 months from initial resolution of the IIH.
CONCLUSION: Idiopathic intracranial hypertension is a chronic condition that may worsen after a period of stability, warranting long-term follow-up.

Entities:  

Mesh:

Year:  2008        PMID: 18285538     DOI: 10.1212/01.wnl.0000299893.43918.a8

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

Review 1.  Headaches associated with papilledema.

Authors:  Robert C Sergott
Journal:  Curr Pain Headache Rep       Date:  2012-08

2.  CVST, distinguished from nonthrombotic CVSS before treatment - a MUST.

Authors:  Ran Meng; Wu Yan; Xiaoying Wang; David Dornbos; Yu Liu; Mingming Ning; Buonanno Ferdinando S; Yuchuan Ding; Xunming Ji
Journal:  Int J Stroke       Date:  2012-04       Impact factor: 5.266

3.  Idiopathic intracranial hypertension is not benign: a long-term outcome study.

Authors:  Hanne M Yri; Marianne Wegener; Birgit Sander; Rigmor Jensen
Journal:  J Neurol       Date:  2011-10-19       Impact factor: 4.849

4.  Diffusion tensor imaging of the optic disc in idiopathic intracranial hypertension.

Authors:  Ahmed Abdel Khalek Abdel Razek; Nihal Batouty; Wesam Fathy; Rania Bassiouny
Journal:  Neuroradiology       Date:  2018-08-22       Impact factor: 2.804

Review 5.  Idiopathic intracranial hypertension in the Middle East: A growing concern.

Authors:  Sumayya J Almarzouqi; Michael L Morgan; Andrew G Lee
Journal:  Saudi J Ophthalmol       Date:  2014-09-28

6.  Ocular ultrasound for monitoring pseudotumor cerebri syndrome.

Authors:  Piergiorgio Lochner; Klaus Fassbender; Martin Lesmeister; Raffaele Nardone; Andrea Orioli; Francesco Brigo; Erwin Stolz
Journal:  J Neurol       Date:  2017-12-14       Impact factor: 4.849

Review 7.  High-pressure headaches: idiopathic intracranial hypertension and its mimics.

Authors:  Kuan-Po Peng; Jong-Ling Fuh; Shuu-Jiun Wang
Journal:  Nat Rev Neurol       Date:  2012-11-20       Impact factor: 42.937

Review 8.  Epidemiology and risk factors for idiopathic intracranial hypertension.

Authors:  John Chen; Michael Wall
Journal:  Int Ophthalmol Clin       Date:  2014

9.  Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension.

Authors:  M Bussière; R Falero; D Nicolle; A Proulx; V Patel; D Pelz
Journal:  AJNR Am J Neuroradiol       Date:  2009-11-26       Impact factor: 3.825

Review 10.  The diagnosis and management of idiopathic intracranial hypertension and the associated headache.

Authors:  Rigmor Højland Jensen; Aleksandra Radojicic; Hanne Yri
Journal:  Ther Adv Neurol Disord       Date:  2016-03-21       Impact factor: 6.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.